Hikma Pharmaceuticals's dividends per share for the
six
months ended in Dec. 2025 was $0.36. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.84. Its Dividend Payout Ratio for the
six
months ended in Dec. 2025 was 0.34. As of today, Hikma Pharmaceuticals's Dividend Yield % is 3.95%.
During the past 12 months, Hikma Pharmaceuticals's average Dividends Per Share Growth Rate was 1.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 13.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 14.00% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 12.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Hikma Pharmaceuticals was 38.40% per year. The lowest was 8.90% per year. And the median was 15.70% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Hikma Pharmaceuticals (OTCPK:HKMPF) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Hikma Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of Hikma Pharmaceuticals was 0.38. The lowest was 0.25. And the median was 0.29.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Hikma Pharmaceuticals Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.480000
2026-03-19
2026-03-20
2026-04-30
Cash Dividend
semi-annually
USD:USD 1.000000
USD 0.360000
2025-08-14
2025-08-15
2025-09-18
Cash Dividend
semi-annually
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Hikma Pharmaceuticals's Dividend Yield (%) for Today is calculated as
Current Share Price is $21.26.
Hikma Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.84.
During the past 13 years, the highest Dividend Yield of Hikma Pharmaceuticals was 5.20%. The lowest was 0.65%. And the median was 1.98%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hikma Pharmaceuticals Dividends per Share Related Terms
Hikma Pharmaceuticals Dividends per Share Historical Data
* Premium members only.
The historical data trend for Hikma Pharmaceuticals's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKMPF vs ZTS, UTHR, VTRS: Dividends per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hikma Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hikma Pharmaceuticals Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hikma Pharmaceuticals's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Hikma Pharmaceuticals's Dividend Yield % falls into.
Hikma Pharmaceuticals (HKMPF) has a Dividends per Share of $0.84 as of Dec. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on Hikma Pharmaceuticals and its competitors.
Is Hikma Pharmaceuticals' Dividends per Share too high?
Hikma Pharmaceuticals' current Dividends per Share is $0.84. Overall, Hikma Pharmaceuticals has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hikma Pharmaceuticals' Dividends per Share compare to ZTS and UTHR?
Hikma Pharmaceuticals' Dividends per Share of $0.84 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Hikma Pharmaceuticals and its competitors. Hikma Pharmaceuticals's current Dividends per Share is $0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hikma Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Hikma Pharmaceuticals (HKMPF) is currently considered Modestly Undervalued. The stock's GF Value™ is $28.52, compared to a current price of $21.26 — trading 25.5% below its estimated fair value. The current Dividends per Share is $0.84. Hikma Pharmaceuticals' overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Hikma Pharmaceuticals (HKMPF), the current Dividends per Share is $0.84 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hikma Pharmaceuticals (HKMPF) Overvalued in 2026?
Based on GuruFocus' analysis, Hikma Pharmaceuticals stock appears to be undervalued.
The current stock price of $21.26 is trading 25.5% below its estimated GF Value™ of $28.52.
GuruFocus considers Hikma Pharmaceuticals to be Modestly Undervalued.
Key valuation signals for HKMPF:
Dividends per Share: $0.84
GF Value™: $28.52 vs. price of $21.26 (25.5% below fair value)
No single metric tells the full story. See the HKMPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, Rx, and branded. The majority of the company's revenue is generated from its injectables segment, which supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue-generating market, followed by the Middle East and North Africa, the United Kingdom, Europe, and the rest of the world.
82GF Score
Get the complete analysis for HKMPF
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKMPF has been successfully added to your 
